Total Payments
$4,418
2024 Payments
$320.64
Companies
20
Transactions
215
Medicare Patients
1,512
Medicare Billing
$298,510
Payment Breakdown by Category
Food & Beverage$4,215 (95.4%)
Education$202.84 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,215 | 212 | 95.4% |
| Education | $202.84 | 3 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $763.42 | 29 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $721.27 | 47 | $0 (2023) |
| Alkermes, Inc. | $472.01 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $455.58 | 24 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $377.24 | 9 | $0 (2024) |
| Indivior Inc. | $301.08 | 15 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $256.13 | 10 | $0 (2023) |
| ABBVIE INC. | $239.81 | 17 | $0 (2024) |
| Lundbeck LLC | $199.32 | 10 | $0 (2024) |
| Axsome Therapeutics, Inc. | $183.71 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $320.64 | 13 | Neurocrine Biosciences, Inc. ($70.37) |
| 2023 | $1,905 | 105 | Teva Pharmaceuticals USA, Inc. ($357.64) |
| 2022 | $1,930 | 84 | Janssen Pharmaceuticals, Inc ($424.69) |
| 2021 | $223.21 | 11 | Janssen Pharmaceuticals, Inc ($88.94) |
| 2020 | $39.18 | 2 | Janssen Pharmaceuticals, Inc ($39.18) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $28.65 | General |
| Category: CNS | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.37 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.16 | General |
| Category: PSYCHIATRY | ||||||
| 05/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $70.37 | General |
| Category: Neuropsychiatry | ||||||
| 03/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: PSYCHIATRY | ||||||
| 02/08/2024 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: OUD | ||||||
| 02/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Neuroscience | ||||||
| 01/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: Psychology/Psychiatric | ||||||
| 01/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: PSYCHIATRY | ||||||
| 01/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: CNS | ||||||
| 12/18/2023 | Alkermes, Inc. | Vivitrol (Drug) | Education | In-kind items and services | $14.85 | General |
| Category: CNS | ||||||
| 12/15/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: BH | ||||||
| 12/14/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $29.54 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Central Nervous System | ||||||
| 12/07/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.40 | General |
| Category: Central Nervous System | ||||||
| 12/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/30/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/09/2023 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: BH | ||||||
| 11/07/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Central Nervous System | ||||||
| 11/02/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: CNS | ||||||
| 11/01/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 493 | 1,595 | $294,104 | $105,131 |
| 2022 | 7 | 416 | 1,411 | $309,596 | $95,742 |
| 2021 | 7 | 439 | 1,106 | $233,626 | $70,727 |
| 2020 | 5 | 164 | 444 | $84,592 | $26,909 |
Total Patients
1,512
Total Services
4,556
Medicare Billing
$298,510
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 90 | 653 | $145,155 | $40,384 | 27.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 402 | $70,152 | $33,075 | 47.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 69 | 72 | $20,106 | $9,417 | 46.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 61 | 61 | $20,314 | $7,990 | 39.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 59 | $13,200 | $7,441 | 56.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 55 | 65 | $19,962 | $4,039 | 20.2% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 34 | 46 | $2,860 | $1,987 | 69.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 51 | 237 | $2,355 | $799.45 | 33.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 94 | 799 | $170,313 | $43,704 | 25.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 67 | 210 | $41,160 | $18,085 | 43.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 80 | 86 | $23,312 | $11,234 | 48.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 50 | $13,750 | $6,853 | 49.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 81 | 104 | $30,620 | $5,717 | 18.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 65 | $19,287 | $5,003 | 25.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 40 | 40 | $10,640 | $4,946 | 46.5% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 16 | 57 | $513.00 | $200.47 | 39.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 118 | 721 | $148,305 | $39,337 | 26.5% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 103 | 111 | $29,251 | $14,316 | 48.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 94 | 104 | $25,364 | $5,789 | 22.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 32 | $6,272 | $3,037 | 48.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 20 | 20 | $5,320 | $2,901 | 54.5% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 56 | 82 | $10,559 | $2,435 | 23.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 18 | 24 | $6,260 | $1,923 | 30.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 12 | 12 | $2,295 | $990.36 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 53 | 303 | $60,808 | $17,429 | 28.7% |
About Dr. Ryan Cox, M.D
Dr. Ryan Cox, M.D is a Psychiatry healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2016. The National Provider Identifier (NPI) number assigned to this provider is 1275983298.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Cox, M.D has received a total of $4,418 in payments from pharmaceutical and medical device companies, with $320.64 received in 2024. These payments were reported across 215 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($4,215).
As a Medicare-enrolled provider, Cox has provided services to 1,512 Medicare beneficiaries, totaling 4,556 services with total Medicare billing of $298,510. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Saginaw, MI
- Active Since 06/21/2016
- Last Updated 06/21/2016
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1275983298
Products in Payments
- SPRAVATO (Drug) $678.67
- ARISTADA (Drug) $436.18
- INGREZZA (Drug) $377.24
- AUSTEDO (Drug) $290.14
- PERSERIS (Drug) $277.73
- REXULTI (Drug) $268.80
- QELBREE (Drug) $256.13
- VRAYLAR (Drug) $239.81
- ABILIFY MAINTENA (Drug) $238.78
- Austedo XR (Drug) $183.76
- Auvelity (Drug) $183.71
- BRINTELLIX (Drug) $147.32
- TRINTELLIX (Drug) $106.91
- CAPLYTA (Drug) $100.35
- INVEGA SUSTENNA (Drug) $84.75
- QUVIVIQ (Drug) $76.59
- IGALMI (Drug) $53.19
- Vivitrol (Drug) $35.83
- UZEDY (Drug) $33.34
- Azstarys (Drug) $30.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saginaw
Dr. Kaushik Raval, M.d, M.D
Psychiatry — Payments: $88,974
Psychiatry $88,974
Dr. Ali Ibrahim, M.d, M.D
Psychiatry — Payments: $5,345
Psychiatry $5,345
Mr. Nicholas Lazurka, (Pa-C), (PA-C)
Psychiatry — Payments: $4,816
Psychiatry $4,816
Mrs. Hema Talasila, M.d, M.D
Psychiatry — Payments: $4,351
Psychiatry $4,351
Dr. Chalichama Rao, M.d, M.D
Psychiatry — Payments: $2,053
Psychiatry $2,053
Samantha Grosteffon
Psychiatry — Payments: $943.34
Psychiatry $943.34